Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...
8hon MSN
Starboard’s Jeff Smith called on the company to assemble a special committee to investigate the matter, describing it as ...
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make ...
Starboard Value LP (together with its affiliates, "Starboard" or "we"), a significant shareholder of Pfizer Inc. (NYSE: PFE) ("Pfizer" or the "Company"), today issued the below letter to Company's ...
An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...
Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the U.S. drug giant to make ...
September CPI rose 0.2%; Weekly jobless claims at 258k. Domino's Pizza misses slightly on revenue, sets cautious guidance; ...
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback